Dermapharm Holding SE Stock

Equities

DMP

DE000A2GS5D8

Pharmaceuticals

Real-time Estimate Tradegate 06:09:03 2024-07-17 am EDT 5-day change 1st Jan Change
35.88 EUR -0.21% Intraday chart for Dermapharm Holding SE -0.42% -15.33%
Sales 2024 * 1.17B 1.28B Sales 2025 * 1.22B 1.34B Capitalization 1.94B 2.11B
Net income 2024 * 102M 111M Net income 2025 * 128M 140M EV / Sales 2024 * 2.35 x
Net Debt 2024 * 808M 882M Net Debt 2025 * 699M 762M EV / Sales 2025 * 2.15 x
P/E ratio 2024 *
19 x
P/E ratio 2025 *
15.1 x
Employees 3,497
Yield 2024 *
2.5%
Yield 2025 *
3.18%
Free-Float 32.26%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.07%
1 week-0.14%
Current month-0.14%
1 month-0.42%
3 months+12.52%
6 months-10.21%
Current year-15.09%
More quotes
1 week
35.55
Extreme 35.55
36.30
1 month
35.15
Extreme 35.15
37.40
Current year
30.80
Extreme 30.8
43.22
1 year
30.80
Extreme 30.8
49.48
3 years
30.80
Extreme 30.8
91.95
5 years
28.06
Extreme 28.055
91.95
10 years
21.58
Extreme 21.575
91.95
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 17-07-31
Director of Finance/CFO - 22-10-31
Investor Relations Contact - 18-11-30
Members of the board TitleAgeSince
Director/Board Member 75 17-12-31
Chairman 68 17-07-31
Director/Board Member 64 17-07-31
More insiders
Date Price Change Volume
24-07-17 35.85 -0.28% 386
24-07-16 35.95 +0.42% 6,479
24-07-15 35.8 -0.56% 7,780
24-07-12 36 -0.41% 7,148
24-07-11 36.15 +0.42% 7,037

Delayed Quote Xetra, July 17, 2024 at 04:22 am EDT

More quotes
Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
35.95 EUR
Average target price
50.12 EUR
Spread / Average Target
+39.43%
Consensus